Release of somatostatin and thyrotropin-releasing hormone from rat hypothalamic fragments in vitro.
D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D066298:In Vitro Techniques; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D018377:Neurotransmitter Agents / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D013004:Somatostatin / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone / Q000378:metabolism*; D014701:Veratridine / Q000494:pharmacology
D018377:Neurotransmitter Agents; D001971:Bromocriptine; D007980:Levodopa; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone; D003994:Bucladesine; D014701:Veratridine; D006220:Haloperidol; D011188:Potassium; D002118:Calcium; D004298:Dopamine